1. Versatile role of curcumin and its derivatives in lung cancer therapy
    Milad Ashrafizadeh et al, 2020, Journal of Cellular Physiology CrossRef
  2. GTP-binding protein Di-RAS3 diminishes the migration and invasion of non-small cell lung cancer by inhibiting the RAS/extracellular-regulated kinase pathway
    Peng Kuang et al, 2022, Bioengineered CrossRef
  3. Reconnoitering the Therapeutic Role of Curcumin in Disease Prevention and Treatment: Lessons Learnt and Future Directions
    Bala Mohan Sivani et al, 2022, Metabolites CrossRef
  4. Antibody Drug Conjugates in Lung Cancer: State of the Current Therapeutic Landscape and Future Developments
    Joshua E. Reuss et al, 2021, Clinical Lung Cancer CrossRef
  5. Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations
    Chunyin Tang et al, 2022, Biomolecules CrossRef
  6. The Potential of Curcumin: A Multitargeting Agent in Cancer Cell Chemosensitization
    Devivasha Bordoloi et al, 2018, Role of Nutraceuticals in Chemoresistance to Cancer CrossRef
  7. Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
    Keisuke Iida et al, 2017, Scientific Reports CrossRef
  8. Curcumin Nanoemulsion: Evaluation of Stability and Anti-Cancer Activity In Vitro
    Thanh Binh Nguyen et al, 2020, Journal of Nano Research CrossRef
  9. Psoralidin protects against cerebral hypoxia/reoxygenation injury: Role of GAS6 /Axl signaling
    Wangrui Lei et al, 2022, Phytotherapy Research CrossRef
  10. Mistletoe ( Viscum album ) extract targets Axl to suppress cell proliferation and overcome cisplatin- and erlotinib-resistance in non-small cell lung cancer cells
    Soyoung Kim et al, 2017, Phytomedicine CrossRef
  11. Antibody–drug conjugates for lung cancer in the era of personalized oncology
    Biagio Ricciuti et al, 2021, Seminars in Cancer Biology CrossRef
  12. Berberine-loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro
    Keshav R. Paudel et al, 2022, Environmental Science and Pollution Research CrossRef
  13. Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer
    Dan Yan et al, 2021, Cancers CrossRef
  14. Giving AXL the axe: targeting AXL in human malignancy
    Carl M Gay et al, 2017, British Journal of Cancer CrossRef
  15. Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration
    Anurima Majumder et al, 2022, Molecular Cancer Research CrossRef
  16. Therapeutic potentials of curcumin in the treatment of non‐small‐cell lung carcinoma
    Mahsa Salehi et al, 2020, Phytotherapy Research CrossRef
  17. Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies
    Alessandro Allegra et al, 2017, Cancer Investigation CrossRef
  18. AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
    Chenjing Zhu et al, 2019, Molecular Cancer CrossRef
  19. Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease
    Sayali Bhave et al, 2021, Biomedicines CrossRef
  20. Nanoscale Formulations: Incorporating Curcumin into Combination Strategies for the Treatment of Lung Cancer
    Quhui Wu et al, 2021, Drug Design, Development and Therapy CrossRef
  21. Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance
    Hongmei Cui et al, 2020, Current Medicinal Chemistry CrossRef
  22. MicroRNA-509-3p inhibits cellular migration, invasion, and proliferation, and sensitizes osteosarcoma to cisplatin
    Sagar L. Patil et al, 2019, Scientific Reports CrossRef
  23. Id-1 promotes osteosarcoma cell growth and inhibits cell apoptosis via PI3K/AKT signaling pathway
    Liang Hao et al, 2016, Biochemical and Biophysical Research Communications CrossRef
  24. Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects
    Milad Ashrafizadeh et al, 2020, Life Sciences CrossRef